Patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) and a history of frequent ‘attacks’ who were given a medicine called astegolimab reported an increase in health-related quality of life compared to those on a placebo, according to findings from a study published in the Lancet Respiratory Medicine.
Global RECHARGE Teach the Teacher course to build capacity for Pulmonary Rehabilitation in low- and middle-income countries
More than 1 in 10 people worldwide have chronic obstructive pulmonary disease (COPD) and many more remain undiagnosed. Most people with COPD live in low- and middle-income countries (LMICs). One of the best ways to help people manage the symptoms and consequences of their COPD is Pulmonary Rehabilitation.Read More
Assessment tool for chronic lung disease could support patients recovering from COVID
Researchers at the National Institute for Health Research (NIHR) Leicester Biomedical Research Centre (BRC) – a partnership between the University of Leicester, Leicester’s Hospitals and Loughborough University – have found that a widely used 8 point questionnaire for COPD and other respiratory conditions may be a useful tool for assessing people’s health during COVID-19 recovery.Read More
Breakthrough research breathes hope into a new treatment for asthma
An international team of scientists, led by the Universities of Leicester and Glasgow, has announced findings that could pave the way to a new treatment for asthma and chronic obstructive pulmonary disease (COPD).Read More